| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 2498092 | Phytomedicine | 2007 | 8 Pages | 
Abstract
												The recently discovered non-mevalonate pathway of isoprenoid biosynthesis serves as the unique source of terpenoids in numerous pathogenic eubacteria and in apicoplast-type protozoa, most notably Plasmodium, but is absent in mammalian cells. It is therefore an attractive target for anti-infective chemotherapy. The first committed step of the non-mevalonate pathway is catalyzed by 2C-methyl-d-erythritol 4-phosphate synthase (IspC). Using photometric and NMR spectroscopic assays, we screened extracts of Mediterranean plants for inhibitors of the enzyme. Strongest inhibitory activity was found in leaf extracts of Cercis siliquastrum.
Keywords
												
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Clinical Biochemistry
												
											Authors
												J. Kaiser, M. Yassin, S. Prakash, N. Safi, M. Agami, S. Lauw, E. Ostrozhenkova, A. Bacher, F. Rohdich, W. Eisenreich, J. Safi, A. Golan-Goldhirsh, 
											